Cancer

Get Email Updates

Resource Centers

Cancer Bloggers

Cancer Guide

Maryann Gromisch RN Guide

Have a question? We're here to help. Ask the Community.

ASK

Free Newsletter

Receive the latest and greatest in women's health and wellness from EmpowHER!

New Device Investigated to Detect Cervical Cancer

By Bonnie Diraimondo RN December 12, 2011 - 12:18am
 
Rate This
0 comments View Comments

According to the National Cancer Institute (NCI) it has designated the LuViva(TM) Advanced Cervical Scan by Guided Therapeutics, Inc. as one of the agency's greatest investments success stories. They have given more than $6 million in successive grants to Guided Therapeutics since 2001 to develop this system.

The device has been tested at 10 clinical centers in the United States upon approximately 3,000 women showing positive results. The device is being reviewed by the FDA (Food and Drug Administration). They are expected to make a decision regarding approval next month, in January 2012.

The LuViva Advanced Cervical Scan created by Guided Therapeutics has been working with the NCI (National Cancer Institute) and is designed to scan the cervix for cancer and precancerous lesions and unlike the Pap, provides immediate results painlessly and non-invasively.

An interesting result of the trial was to show that cervical disease was just as likely to occur in women in the age group 16-20 as it was in those over 20. This is in direct contradiction with guidelines currently proposed which would eliminate Pap testing on women under 21 in the United States. LuViva was shown to detect cervical disease two years in advance of the Pap, HPV tests, colposcopy or biopsy.

This will certainly create a contradiction when it comes to cervical cancer screening guidelines now being finalized. Screening guidelines are looking to eliminate testing for women under 21, stating that cancer in this age group is low, but whom according to the LuViva tests, are just as likely to develop cancer as their older counterparts.

Women’s groups may question why the guidelines are attempting to eliminate early diagnosis for women under 21 who are just as deserving of an early diagnosis as older women.

Sources:

"Guided Therapeutics | LuViva ." Guided Therapeutics | Home Page . N.p., n.d. Web. 12 Dec. 2011.
http://www.guidedinc.com/LuViva/index.htm

"National Cancer Institute Designates Guided Therapeutics’ LuViva™ Advanced … – TradersHuddle.com (press release)." HPV DNA Test - Human Papillomavirus . N.p., n.d. Web. 12 Dec. 2011.

 
Rate This
0 comments View Comments

We value and respect the experiences of all of our HERWriters, but everyone is different. Many of our writers are speaking from personal experience, and what's worked for them may not work for you. Their articles are not a substitute for medical advice although we hope you can gain knowledge from their insight.

Bonnie Diraimondo RN View Profile Send Message

Bonnie Diraimondo is an RN and a patient advocate regarding HPV issues. She is an international speaker, author,and ...

http://www.thehpvsupportnetwork.org

Tags

Add a CommentComments

There are no comments yet. Be the first one and get the conversation started!

Image CAPTCHA
By hitting submit, you agree to EmpowHER's terms of service and privacy policy

Improved

616 Health

Changed

293 Lives

Saved

210 Lives
3 lives impacted in the last 24 hrs Learn More

Health Theater Videos

View More Videos

Take our Featured Poll

Have you ever participated in a clinical trial?:
View Results